Disclaimer:All content on this platform is sourced from the internet and is provided for informational purposes only. None of the content represents the views of this site, nor does it constitute investment advice. Please exercise caution when investing.

Faster global financial news!

ResMed Inc.

RMD NYSEHealthcare ★★★★★
Market Cap $33.58B
Latest Earnings
Date
Aug 6, 2026
ET
EPS Est.
2.89
EPS Actual
2.95
Revenue Est.
$1.46B
Revenue Actual
$1.46B
Next Earnings Report
Date
Oct 29, 2026 · Thu
Time
After-market
Fiscal Period
FY2027 Q1
EPS Est.
2.69
Revenue Est.
$1.39B
Company Overview
ResMed Inc. (ticker RMD) is listed on NYSE with a market cap of about $33.58B. Its next earnings report (FY2027 Q1) is expected on Oct 29, 2026 (ET), After-market, with consensus EPS of 2.69. In the last 15 reported quarters, EPS beat consensus estimates 12 times.
Actual EPS TrendRecently15Term · Jan 26, 2023 → Aug 6, 2026
Jan 26, 2023Range: 1.60 ~ 2.95Aug 6, 2026
Earnings History
Date Fiscal Period EPS Est. EPS Actual Revenue Est. Revenue Actual
Aug 6, 2026 -- 2.89 2.95 $1.46B $1.46B
Apr 30, 2026 -- 2.80 2.86 $1.42B $1.43B
Jan 29, 2026 -- 2.74 2.81 $1.4B $1.42B
Oct 30, 2025 -- 2.51 2.55 $1.33B $1.34B
Jul 31, 2025 -- 2.55 2.55 $1.35B $1.35B
Apr 23, 2025 -- 2.38 2.37 $1.29B $1.29B
Jan 30, 2025 -- 2.32 2.43 $1.27B $1.28B
Oct 24, 2024 -- 2.04 2.20 $1.19B $1.22B
Aug 1, 2024 -- 2.07 2.08 $1.22B $1.22B
Apr 25, 2024 -- 1.91 2.13 $1.17B $1.2B
Jan 24, 2024 -- 1.81 1.88 $1.15B $1.16B
Oct 26, 2023 -- 1.62 1.64 $1.1B $963M
Aug 3, 2023 -- 1.69 1.60 $1.14B $1.12B
Apr 27, 2023 -- 1.59 1.68 $1.13B $1.12B
Jan 26, 2023 -- 1.62 1.66 $996.1M $1.03B
Original Filings (SEC)
Links point to the company's original filings on the U.S. Securities and Exchange Commission (SEC) website.
Report dates are US trading days (Eastern Time); EPS and revenue estimates are market consensus, in USD. This page is for reference only and does not constitute investment advice.
Current Location: Home > Economic Calendar > Earnings Calendar > RMD